UNICEF, the UN agency responsible for providing humanitarian and developmental aid to children worldwide, said on 23 February 2021 that it had sent an initial 100,000 syringes for COVID-19 vaccines to the Maldives in preparation for first deliveries of Pfizer and AstraZeneca shots under the COVAX vaccine-sharing plan, Reuters news agency reported on Tuesday.
According to the UNICEF, the syringes, as well as 1,000 safety boxes for vaccine storage, are expected to arrive in the Maldives on 23 February 2021.
Other recipient countries in the first wave of shipments include Ivory Coast and Sao Tome and Principe.
In a statement, the UNICEF said that the shipment of 23 February 2021 will be followed in the next few weeks by deliveries of about 14.5 million 0.5 millilitre (ml) and 0.3 ml syringes to over 30 countries.
The COVAX facility, co-led by the World Health Organisation, the GAVI vaccine alliance and others, had allocated about 330 million doses of COVID-19 vaccines for poorer countries earlier in February 2021. It aims to deliver these and millions more in the first half of 2021.
UNICEF said the 0.5 ml syringes would be for use with the AstraZeneca COVID-19 vaccine made by Serum Institute of India, while the 0.3 ml ones would be for the Pfizer-BioNTech shot.
UNICEF's executive director, Henrietta Fore, was quoted as saying: "It is critical to have adequate supplies of syringes already in place in every country before the vaccine arrives so that the vaccine can be administered safely," adding, "This would allow immunisation to start immediately and "help turn the tide on this terrible virus".
Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management
ALK secures EU approval for EURneffy 1 mg as needle-free adrenaline option for children
Delonix Bioworks launches Phase 1 trial of next-generation MenB OMV vaccine DX-104
Hengrui Pharma and Braveheart Bio report positive Phase 2 results for HRS/BHB-1893 in oHCM
Innovent and Ollin Biosciences report IBI324 study data in wAMD and DME
Boston Scientific receives FDA clearance for Asurys fluid management system
GSK's bepirovirsen accepted for review in China as potential Hepatitis B functional cure
4DMedical secures EU approval for CT:VQ as EUR83m funding fuels European expansion
Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences
GXO appointed to manage NHS England bowel cancer home testing kits